Cargando…

Molecular dissection of ependymomas

Detalles Bibliográficos
Autores principales:	Pajtler, Kristian W., Pfister, Stefan M., Kool, Marcel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671940/ https://www.ncbi.nlm.nih.gov/pubmed/26682265

Ejemplares similares

TB-06 MOLECULAR MECHANISM OF BRAIN TUMOUR FORMATION DRIVEN BY SUPRATENTORIAL EPENDYMOMA-SPECIFIC YAP1 FUSION GENES
por: Kawauchi, Daisuke, et al.
Publicado: (2019)

EPEN-12. COMPARING CELLULAR HIERARCHIES AND SPATIAL ARCHITECTURE ACROSS MOLECULAR SUBGROUPS OF SUPRATENTORIAL EPENDYMOMAS
por: Jeong, Daeun, et al.
Publicado: (2023)

EZHIP: a new piece of the puzzle towards understanding pediatric posterior fossa ependymoma
por: Jenseit, Anne, et al.
Publicado: (2021)

EPEN-28. Oncogenic dependency of pediatric ependymomas on extracellular vesicle pathways
por: Maass, Kendra K, et al.
Publicado: (2022)

Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymoma
por: Tzaridis, Theophilos, et al.
Publicado: (2016)

EPEN-03. USP7 is an interaction partner of EZHIP and potential druggable target in PFA ependymomas
por: Jenseit, Anne, et al.
Publicado: (2022)

Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging
por: Pagès, Mélanie, et al.
Publicado: (2018)

Limitations of current in vitro models for testing the clinical potential of epigenetic inhibitors for treatment of pediatric ependymoma
por: Rogers, Hazel Anne, et al.
Publicado: (2018)

EPEN-44. EXTRACELLULAR VESICLES OF SUPRATENTORIAL EPENDYMOMA RELA MEDIATE INTERACTIONS WITH CELLS OF THE TUMOR MICROENVIRONMENT
por: Maass, Kendra K, et al.
Publicado: (2020)

EPEN-39. CLINICAL STRATIFIED TREATMENT OF LOCALIZED PEDIATRIC INTRACRANIAL EPENDYMOMA WITH COMBINED LOCAL IRRADIATION AND CHEMOTHERAPY WITHIN THE PROSPECTIVE, MULTICENTER E-HIT TRIAL – THE MOLECULAR SUBGROUP MATTERS
por: von Hoff, Katja, et al.
Publicado: (2020)

EPEN-03. ZFTA/C11ORF95 FUSIONS DRIVE SUPRATENTORIAL EPENDYMOMA VIA SHARED ONCOGENIC MECHANISMS
por: Zheng, Tuyu, et al.
Publicado: (2021)

MYCN amplification drives an aggressive form of spinal ependymoma
por: Ghasemi, David R., et al.
Publicado: (2019)

The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants
por: Pajtler, Kristian W., et al.
Publicado: (2016)

EPEN-06. CHEMOTHERAPY OF RECURRENT EPENDYMOMA: LONG-TERM RESPONSE ONLY IN FEW CASES
por: Adolph, Jonas, et al.
Publicado: (2020)

EPEN-47. PEDS: PEDIATRIC EPENDYMOMA DISCOVERY STUDY
por: Smith, Amy, et al.
Publicado: (2020)

EPEN-04. ONCOGENIC 3D TUMOR GENOME ORGANIZATION IDENTIFIES NEW THERAPEUTIC TARGETS IN EPENDYMOMA
por: Okonechnikov, Konstantin, et al.
Publicado: (2020)

Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies
por: Adolph, Jonas E., et al.
Publicado: (2021)

EPEN-18. CROSS-SPECIES GENOMICS IDENTIFIES GLI2 AS AN ONCOGENE OF C11orf95 FUSION-POSITIVE SUPRATENTORIAL EPENDYMOMA
por: Zheng, Tuyu, et al.
Publicado: (2020)

Pediatric ependymomas: destined to recur?
por: Ritzmann, Timothy A, et al.
Publicado: (2021)

YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis
por: Pajtler, Kristian W., et al.
Publicado: (2019)

Clinically aggressive pediatric spinal ependymoma with novel MYC amplification demonstrates molecular and histopathologic similarity to newly described MYCN-amplified spinal ependymomas
por: Shatara, Margaret, et al.
Publicado: (2021)

Update on molecular and genetic alterations in adult medulloblastoma
por: Kool, Marcel, et al.
Publicado: (2012)

Molecular genetics of ependymoma
por: Yao, Yuan, et al.
Publicado: (2011)

EPEN-18. Oncogenic 3D genome conformations identify novel therapeutic targets in ependymoma
por: Okonechnikov, Konstantin, et al.
Publicado: (2022)

A multi-institutional retrospective pooled outcome analysis of molecularly annotated pediatric supratentorial ZFTA-fused ependymoma
por: Ng, Chia Huan, et al.
Publicado: (2023)

EPEN-10. SPINAL EPENDYMOMA WITH MYCN-AMPLIFICATION – A DISEASE OF CHILDHOOD AND YOUNG ADULTHOOD WITH DISMAL PROGNOSIS
por: Ghasemi, David R, et al.
Publicado: (2023)

EPEN-09. IMPACT OF MOLECULAR SUBGROUP ON OUTCOME FOR INFANTS <12 MONTHS WITH INTRACRANIAL EPENDYMOMA - GERMAN EXPERIENCE FROM HIT2000, INTERIM-2000-REGISTRY AND I-HIT-MED REGISTRY
por: Obrecht, Denise, et al.
Publicado: (2020)

Targeting fibroblast growth factor receptors to combat aggressive ependymoma
por: Lötsch, Daniela, et al.
Publicado: (2021)

EPEN-24. Biological markers of ependymoma in children and adolescents (BIOMECA): Systematic comparison of methods for the precise evaluation of biomarkers for ependymoma diagnosis and prognostication
por: Chapman, Rebecca, et al.
Publicado: (2022)

Single-Cell RNA-Seq Reveals Cellular Hierarchies and Impaired Developmental Trajectories in Pediatric Ependymoma
por: Gojo, Johannes, et al.
Publicado: (2020)

EPEN-21. IMPAIRED NEURONAL-GLIAL FATE SPECIFICATION IN PEDIATRIC EPENDYMOMA REVEALED BY SINGLE-CELL RNA-SEQ
por: Englinger, Bernhard, et al.
Publicado: (2020)

SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort—A BIOMECA Consortium Study
por: Ritzmann, Timothy A, et al.
Publicado: (2022)

Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study
por: Chapman, Rebecca J, et al.
Publicado: (2023)

Molecular Classification and Therapeutic Targets in Ependymoma
por: Larrew, Thomas, et al.
Publicado: (2021)

Therapeutic Targeting of Ependymoma as Informed by Oncogenic Enhancer Profiling
por: Mack, Stephen C., et al.
Publicado: (2017)

EPEN-04. SIOP EPENDYMOMA I: FINAL RESULTS, LONG TERM FOLLOW-UP AND MOLECULAR ANALYSIS OF THE TRIAL COHORT: A BIOMECA CONSORTIUM STUDY
por: A. Ritzmann, Timothy, et al.
Publicado: (2021)

3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma
por: Okonechnikov, Konstantin, et al.
Publicado: (2023)

Ependymomas
por: Bertero, Luca, et al.
Publicado: (2022)

Unique Molecular Characteristics of Pediatric Myxopapillary Ependymoma
por: Barton, Valerie N., et al.
Publicado: (2009)

PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation
por: van Vuurden, Dannis G., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_7vfftg2p2b199hh0raqqie0404